AG
KNTE
Artal Group’s Kinnate Biopharma Inc. Common Stock KNTE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-125,000
| Closed | -$379K | – | 120 |
|
|
2023
Q2 | $379K | Hold |
125,000
| – | – | 0.01% | 104 |
|
|
2023
Q1 | $781K | Hold |
125,000
| – | – | 0.05% | 95 |
|
|
2022
Q4 | $763K | Hold |
125,000
| – | – | 0.04% | 103 |
|
|
2022
Q3 | $1.49M | Hold |
125,000
| – | – | 0.06% | 96 |
|
|
2022
Q2 | $1.58M | Hold |
125,000
| – | – | 0.08% | 105 |
|
|
2022
Q1 | $1.41M | Hold |
125,000
| – | – | 0.06% | 115 |
|
|
2021
Q4 | $2.22M | Hold |
125,000
| – | – | 0.06% | 124 |
|
|
2021
Q3 | $2.88M | Hold |
125,000
| – | – | 0.06% | 121 |
|
|
2021
Q2 | $2.91M | Hold |
125,000
| – | – | 0.06% | 124 |
|
|
2021
Q1 | $3.9M | Hold |
125,000
| – | – | 0.07% | 116 |
|
|
2020
Q4 | $4.97M | Buy |
+125,000
| New | +$4.97M | 0.11% | 101 |
|